Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

Sector

Healthcare Facilities & Services

More about the company

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Real-time Estimate Tradegate 16:02:43 2026-08-18 EDT			5-day change	1st Jan Change
0.1528 ^EUR	-63.36%		0.00%	-

07-29	EQT to sell Quantios to Vista Equity Partners	FW
07-15	Klea Holding targets improved profitability in the second half

Market Cap	46.91M 54.31M 44.13M 40.11M 75.44M 5.2B 76.55M 518M 203M 2.6B 204M 199M 8.67B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	47.03M 54.45M 44.25M 40.22M 75.65M 5.22B 76.75M 519M 203M 2.61B 204M 200M 8.69B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

07-29	EQT to sell Quantios to Vista Equity Partners	FW
07-15	Klea Holding targets improved profitability in the second half
06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
03-31	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
25-10-27	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
25-10-27	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT

07-15	Klea : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	PU
07-15	Klea Holding : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	AT
06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT

Visiomed Group Stock London S.E.

Stocks

0D13

FR0013481835

Healthcare Facilities & Services

Valuation: Visiomed Group

Chart: Visiomed Group

Latest news : Visiomed Group

Analysts' recommendations: Visiomed Group

Press Releases: Visiomed Group

News in other languages: Visiomed Group

Quotes and Performance

Managers and Directors: Visiomed Group

Other Healthcare Facilities & Services

Financials

Company Profile

Income Statement and Estimates

Annual profits - Rate of surprise

08-17	Klea : Déclaration des transactions sur actions propres
08-17	Klea Holding : Déclaration des transactions sur actions propres
07-27	Klea Holding : Déclaration des transactions sur actions propres
07-20	Klea Holding : Déclaration des transactions sur actions propres
07-15	Klea Holding vise une amélioration de sa rentabilité au second semestre

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	2024-01-21
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	2022-03-31

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	2022-03-31
Paul Amsellem BRD	Director/Board Member	51	2023-06-13

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VISIOMED GROUP	-63.36%	0.00%	-	-	54.26M
CVS HEALTH CORPORATION	+0.96%	-0.79%	+38.35%	+42.08%	120B
HCA HEALTHCARE, INC.	+1.67%	-0.56%	+4.03%	+55.01%	87.68B
QUEST DIAGNOSTICS INCORPORATED	+0.31%	-0.58%	+31.42%	+78.65%	26B
TENET HEALTHCARE CORPORATION	+2.14%	+3.95%	+57.08%	+279.30%	21.3B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.29%	+1.59%	-7.11%	-9.12%	21.53B
REDE D'OR SÃO LUIZ S.A.	-0.85%	-1.09%	-14.13%	+10.32%	13.92B
FRESENIUS MEDICAL CARE AG	-0.17%	-3.76%	-4.48%	-9.83%	12.52B
DAVITA INC.	+0.68%	-3.15%	+31.42%	+76.78%	11.27B
PT SEJAHTERARAYA ANUGRAHJAYA TBK	0.00%	+15.38%	+152.10%	+2,172.73%	10.29B
Average	+0.58%	+0.18%	+32.07%	+299.55%	36.08B
Weighted average by Cap.	+0.79%	-1.13%	+26.21%	+126.03%

	2024	2025
Net sales	17.26M 19.98M 16.24M 14.76M 27.76M 1.91B 28.17M 190M 74.65M 958M 75.03M 73.4M 3.19B	22.17M 25.66M 20.86M 18.95M 35.65M 2.46B 36.17M 245M 95.87M 1.23B 96.36M 94.26M 4.1B
Net income	1.4M 1.63M 1.32M 1.2M 2.26M 156M 2.29M 15.51M 6.08M 77.95M 6.11M 5.97M 260M	2.28M 2.64M 2.15M 1.95M 3.67M 253M 3.72M 25.17M 9.87M 127M 9.92M 9.7M 422M
Net Debt	2.58M 2.98M 2.42M 2.2M 4.14M 286M 4.2M 28.42M 11.14M 143M 11.19M 10.95M 476M	125K 145K 118K 107K 201K 13.87M 204K 1.38M 541K 6.94M 543K 532K 23.1M